Statin therapy for acute respiratory distress syndrome: an individual patient data meta-analysis of randomised clinical trials

[1]  Y. Cho,et al.  Preadmission Statin Therapy Is Associated with a Lower Incidence of Acute Kidney Injury in Critically Ill Patients: A Retrospective Observational Study , 2018, Journal of clinical medicine.

[2]  Focus on randomised clinical trials , 2018, Intensive Care Medicine.

[3]  Klaus Ulrich Klein,et al.  Faculty of 1000 evaluation for Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. , 2018 .

[4]  M. Terblanche,et al.  Statins in patients with sepsis and ARDS: is it over? No , 2017, Intensive Care Medicine.

[5]  W. Alhazzani,et al.  Statins in patients with sepsis and ARDS: is it over? Yes , 2017, Intensive Care Medicine.

[6]  L. Papazian,et al.  Statins in patients with sepsis and ARDS: is it over? We are not sure , 2017, Intensive Care Medicine.

[7]  M. Balaan,et al.  Acute Respiratory Distress Syndrome , 2016, Critical care nursing quarterly.

[8]  Anders Larsson,et al.  Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. , 2016, JAMA.

[9]  R. Barrera,et al.  Incidence of Sepsis and Mortality With Prior Exposure of HMG-COA Reductase Inhibitors in a Surgical Intensive Care Population , 2016, Shock.

[10]  J. Hunt,et al.  Effect of Simvastatin on Physiological and Biological Outcomes in Patients Undergoing Esophagectomy: A Randomized Placebo-controlled Trial. , 2015, Annals of surgery.

[11]  J. Marshall,et al.  Core Outcomes in Ventilation Trials (COVenT): protocol for a core outcome set using a Delphi survey with a nested randomised trial and observational cohort study , 2015, Trials.

[12]  T. Beißbarth,et al.  Impact of statin therapy on mortality in patients with sepsis-associated acute respiratory distress syndrome (ARDS) depends on ARDS severity: a prospective observational cohort study , 2015, BMC Medicine.

[13]  D. Ouellette,et al.  Sepsis outcomes in patients receiving statins prior to hospitalization for sepsis: comparison of in-hospital mortality rates between patients who received atorvastatin and those who received simvastatin , 2015, Annals of Intensive Care.

[14]  M. Rothberg,et al.  Statin therapy and mortality from sepsis: a meta-analysis of randomized trials. , 2015, The American journal of medicine.

[15]  A. Loundou,et al.  Statin therapy in critically-ill patients with severe sepsis: a review and meta-analysis of randomized clinical trials. , 2015, Minerva anestesiologica.

[16]  G. Perkins,et al.  Simvastatin in the acute respiratory distress syndrome. , 2014, The New England journal of medicine.

[17]  H. Ni,et al.  Do the observational studies using propensity score analysis agree with randomized controlled trials in the area of sepsis? , 2014, Journal of critical care.

[18]  Kevin Delucchi,et al.  Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. , 2014, The Lancet. Respiratory medicine.

[19]  H. El Gendy,et al.  Safety and vasopressor effect of rosuvastatin in septic patients , 2014 .

[20]  I. Douglas,et al.  Rosuvastatin for sepsis-associated acute respiratory distress syndrome. , 2014, The New England journal of medicine.

[21]  E. Ely,et al.  Statin use and risk of delirium in the critically ill. , 2014, American journal of respiratory and critical care medicine.

[22]  K. Baumstarck,et al.  Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial. , 2013, JAMA.

[23]  G. Perkins,et al.  Statins and sepsis: potential benefit but more unanswered questions. , 2013, American journal of respiratory and critical care medicine.

[24]  R. Bellomo,et al.  A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis. , 2013, American journal of respiratory and critical care medicine.

[25]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration , 2013 .

[26]  Douglas G. Altman,et al.  Statistical Analysis of Individual Participant Data Meta-Analyses: A Comparison of Methods and Recommendations for Practice , 2012, PloS one.

[27]  G. Perkins,et al.  Statin therapy in critical illness: an international survey of intensive care physicians’ opinions, attitudes and practice , 2012, BMC clinical pharmacology.

[28]  A. Komnos,et al.  Effect of pravastatin on the frequency of ventilator-associated pneumonia and on intensive care unit mortality: Open-label, randomized study* , 2011, Critical care medicine.

[29]  J. Sterne,et al.  The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.

[30]  J F Tierney,et al.  A critical review of methods for the assessment of patient-level interactions in individual participant data meta-analysis of randomized trials, and guidance for practitioners. , 2011, Journal of clinical epidemiology.

[31]  M. Sampson,et al.  Checking reference lists to find additional studies for systematic reviews. , 2011, The Cochrane database of systematic reviews.

[32]  J. Kirk-Bayley,et al.  Functional Disability 5 Years after Acute Respiratory Distress Syndrome , 2011 .

[33]  K. Kostner,et al.  Continuation of statin therapy in patients with presumed infection: a randomized controlled trial. , 2011, American journal of respiratory and critical care medicine.

[34]  D. McAuley,et al.  A randomized clinical trial of hydroxymethylglutaryl- coenzyme a reductase inhibition for acute lung injury (The HARP Study). , 2011, American journal of respiratory and critical care medicine.

[35]  J. Higgins.  Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration , 2011 .

[36]  R. Riley,et al.  Meta-analysis of individual participant data: rationale, conduct, and reporting , 2010, BMJ : British Medical Journal.

[37]  Alex J Sutton,et al.  Statins for the prevention and treatment of infections: a systematic review and meta-analysis. , 2009, Archives of internal medicine.

[38]  J. Backman,et al.  Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers. , 2009, American journal of respiratory and critical care medicine.

[39]  M. Falagas,et al.  Statins for sepsis: a critical and updated review. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[40]  M. Falagas,et al.  Statins for infection and sepsis: a systematic review of the clinical evidence. , 2008, The Journal of antimicrobial chemotherapy.

[41]  Arthur S Slutsky,et al.  Two-year outcomes, health care use, and costs of survivors of acute respiratory distress syndrome. , 2006, American journal of respiratory and critical care medicine.

[42]  R. Rosenson,et al.  Statins: panacea for sepsis? , 2006, The Lancet. Infectious diseases.

[43]  G. Iapichino,et al.  Variable costs of ICU patients: a multicenter prospective study , 2006, Intensive Care Medicine.

[44]  Diane P. Martin,et al.  Incidence and outcomes of acute lung injury. , 2005, The New England journal of medicine.

[45]  D. Grigoryev,et al.  Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[46]  Mark Jones,et al.  Statin therapy is associated with fewer deaths in patients with bacteraemia , 2005, Intensive Care Medicine.

[47]  M. Lamy,et al.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.